Skip Ribbon Commands
Skip to main content
Menu

Breast Cancer

Breast Cancer - How to prevent?

Breast Cancer - Treatments

Treatment of breast cancer may include various methods, such as surgery with or without breast reconstruction, chemotherapy, radiation therapy, hormonal therapy and targeted therapy. Treatment options offered depend on a number of factors, such as the stage of cancer and likelihood of cure, your general health and your preference. Being diagnosed with breast cancer and having to decide on the treatment option is one of the most difficult decisions you will ever have to make. Have someone close to accompany you when visiting the doctor to discuss the result of your tests and treatment options.

Surgery

A lumpectomy or mastectomy is one of the most common treatments for breast cancer. The type of surgical treatment depends on the stage of the cancer, size of the tumour, in relation to the breast size, whether breast preservation is desired and your feelings about the options.

Breast Conserving Surgery (BCS) Wide Excision/ Lumpectomy

  • Your surgeon will remove only the breast cancer and a rim of normal surrounding breast tissue.
  • Your breast will remain. A scar and some changes in shape and size are expected.
  • You can go home the next day.
  • You may require a second operation if cancer cells are noted at the edge of the removed portion. This occurs in 10-15% of patients.
  • You will need to have radiation therapy to the breast (Mon to Fri) for 4-6 weeks. This helps to destroy any remaining cancer cells.

Sentinel Lymph Node Biopsy (SLNB)

  • If you have early stage breast cancer, and the lymph nodes in your underarm do not appear to have cancer, SLNB will be carried out.
  • The first few lymph nodes (sentinel lymph nodes, SLN) in your underarm where the lymphatic vessels from the breast drain to, will be removed and examined during surgery under the microscope (frozen section).
  • This is done under General Anaesthesia GA (asleep) and it is to determine if cancer has spread to these SLN.
  • A blue dye or a radioactive substance is injected around the cancer site or at the nipple prior to surgery to locate the SLN.
    - The radioactive substance will be injected before the operation in the Department of Nuclear Medicine.
    - The blue dye will be injected during the operation.
  • If cancer is detected in the SLN, lymph nodes in the axilla are removed. If no cancer is detected in the SLN, no further surgery is needed.
  • The final histology will be reviewed about 1 week after surgery.
  • In 2 - 3% of cases, the final assessment of the SLN may be different from the initial frozen section result and a second operation may be required.
  • If the dye or radioactive substance is not able to identify the SLN, we will have to proceed to perform an axillary clearance.

Axillary Clearance

  • Involves the removal of all lymph nodes from the underarm.
  • This is needed because the lymph nodes are found to have cancer cells.
  • Side Effects:
    1. Shoulder stiffness.
    2. Swelling of the arm (lymphedema) 15-20%.
    3. Numbness of the inner part of your upper arm.

X-ray Guided or Ultrasound Guided Hookwire Localisation for Surgery

  • This procedure is performed under local anaesthesia, before you go for surgery.
  • Mammogram or ultrasound guidance is used to place a fine wire within the breast in close proximity to the lesion of interest.
  • This wire marks the lesion to be removed.
  • The wire and lesion of interest will be removed during the surgery.

Oncoplastic Breast Conserving Surgery

Mammoplasty (Breast lift / Breast reduction)

  • All the points for Breast Conserving Surgery mentioned earlier are applicable.
  • In addition, you will benefit from the re-shaping of the breast after cancer removal.
  • This is performed to reduce breast deformity and improve the final appearance of the breast after cancer removal.
  • If your cancer is large, the final breast volume may be smaller. Surgery to the opposite breast for better symmetry may be performed at the same time, or at a later date.
  • Speak to your surgeon for specific details of this surgery.

Partial breast reconstruction (volume replacement) with a perforator flap

  • All the points for Breast Conserving Surgery mentioned earlier are applicable.
  • You are suitable for partial breast reconstruction (volume replacement) with breast conserving surgery.
  • Fatty tissue next to your breast will be used to fill the space in the breast that results from cancer removal.
  • This maintains breast volume and contour, reducing breast deformity.
  • Speak to your surgeon for specific details on this surgery.

Simple Mastectomy

  • The entire breast, including the nipple-areola complex is removed. After surgery, a neat and flat chest wound is expected.
  • A soft tubing known as a drain is placed during surgery with the accompanying bottle to remove blood and fluid accumulated at the operated site.
  • The drain is removed when the drainage is less than 30ml/ 24h after 1-2 weeks. You will be taught how to care for the drain.
  • You can go home the next day.

Mastectomy with Breast Reconstruction

  • Immediate: You have chosen to have breast reconstruction at the time of mastectomy.
    - Skin sparing mastectomy: where most of the skin of your breast will be preserved.
    - Nipple sparing mastectomy: In suitable cases, the nipple may be preserved if tissue from the base of the nipple shows no cancer cells when tested at the time of surgery. However, if the final histology results show cancer cells behind the nipple, you will be recommended a simple surgery to remove it.
  • Delayed: Breast reconstruction may also be done at a later stage, separate from the initial breast surgery.

Types of Breast Reconstruction

Flap reconstruction

  • Skin, fat and sometimes muscle (a flap) from another part of your body may be used to make it into a breast shape.
  • The operation duration is about 6 - 8 hours.
  • Hospital stay is between 1 - 2 weeks.
  • Several drains are used and removed after 1 - 2 weeks.
  • Flaps may be from the:
    - Back (latissimus dorsi)
    - Abdomen
    - Trans-rectus Abdominis Muscle (Tram) Flap Reconstruction
    - DIEP (deep inferior epigastric perforator) flap, taking skin and fat only Buttock/Thigh

Breast Implants

  • Silicone implants may be used to create a new breast.
  • The operation duration is about 4 - 5 hours.
  • Usually there are 2 - 3 drainage bottles inserted.
  • Hospital stay is 3 - 5 days.
  • 1-stage: The permanent implant is inserted at the time of mastectomy.
  • 2-stage: A temporary expander may be placed at time of mastectomy, and gradually expanded to stretch the skin and the expander is exchanged for a permanent implant at a later surgery.

Chemotherapy

This treatment method uses anti-cancer drugs to kill cancer cells. They stop cancer cells from growing and reproducing themselves. These drugs can be given orally (by mouth) or by injection where it enters the blood stream and travels throughout the body. It may be used alone, before (neoadjuvant) or after (adjuvant) surgery, or together with radiation therapy to increase the effectiveness of treatment, depending on the stage of cancer.

Chemotherapy is given in cycles. Each cycle consists of a treatment period followed by a resting (recovery) period. As cancer drugs also affect normal cells, the resting period is to allow the body to recover before the next treatment cycle starts. There are side effects associated with chemotherapy such as hair loss, nausea and vomiting, loss of appetite, mouth ulcers and risk for infection. However, these are temporary and steps can be taken to prevent or reduce them.

Radiation Therapy

High-energy rays are used to kill cancer cells or stop them from growing further. Although radiation therapy can affect both cancer cells as well as normal cells, the aim of radiation is to destroy more cancer cells and spare as many normal cells as possible. Radiation therapy is given to the affected breast after a lumpectomy. In some circumstances, it may be given to the chest wall after a mastectomy. It is given 5 days a week on weekdays, over a period of 5 or 6 weeks. Radiation therapy can cause some side effects which vary among individuals.

The most common side effect is redness and dryness of the skin. Skin texture also becomes darker and thicker. The breast may swell, and increase or decrease in sensitivity. Usually, these effects start to get better when your treatment is completed.

Intraoperative Radiation Therapy (IORT) involves the use of the Intrabeam® device to irradiate the tumour site during the surgery. The administration is done immediately after lumpectomy, also known as breast-conserving surgery. This procedure takes about 20 to 40 minutes. This radiotherapy regime is suitable for some early-stage patients. This treatment may be proposed to patients in the early stage of the disease who opt to keep their breasts.

Hormone Therapy

Some breast cancers grow with the influence of hormones. Patients with both oestrogen receptor (ER) and progesterone receptor (PR) positivity have the best chance of responding to hormonal therapy. Hormone therapy in breast cancer is aimed at affecting oestrogen, a hormone that is required for the cancer to grow. For some women with early breast cancer, anti-cancer hormone treatment may be used as an additional treatment to reduce the chances of breast cancer recurrence. Hormone therapy can cause some side effects. These are dependent on the type of drugs taken and can vary from one patient to another.

Tamoxifen is the most common drug used in this treatment. This drug blocks the action of oestrogen on the body but does not stop oestrogen from being produced. Tamoxifen may cause hot flashes, depression or mood swings, vaginal discharge or irritation, irregular menstrual periods and sometimes menopause. Any unusual bleeding should be reported to the doctor.

Serious side effects from Tamoxifen are rare but Tamoxifen can cause the formation of blood clots in the veins, especially in the legs. In a very small number of women, Tamoxifen can cause cancer in the lining of the uterus. You may be referred to a gynaecologist to evaluate any unusual bleeding.

Aromatase Inhibitors (AI)

For post-menopausal women, another group of drugs called aromatase inhibitors (AIs) is also used in breast cancer hormonal treatment. Aromatase inhibitors work by blocking an enzyme called aromatase that the body uses to produce oestrogen. The current AIs such as anastrozole, letrozole and exemastane, are well tolerated and are used in the treatment of early stage and advanced breast cancer. Side effects of AI include hot flashes, mood changes, nausea, vagina dryness, joint pain/stiffness, tiredness, lethargy and osteoporosis (including a higher risk of fractures compared to Tamoxifen).

You can discuss with your doctor, Breast Care Nurse or pharmacist on what to expect and how to care for yourself during treatment. If there are more concerns, you can also contact the Cancer Helpline at tel: 6225 5655.

Targeted Therapy

Targeted therapy is a form of cancer treatment that involves the use of antibodies or small molecules to bind to specific sites on cancer cells in order to prevent cell growth and division. The aim of the treatment is to reduce or eliminate existing cancer cells in the human body while minimizing side effects on normal cells.

An example of targeted therapy for breast cancer is Trastuzumab (Herceptin®). It is an antibody which targets the HER2 (Human Epidermal Growth Factor Receptor). This receptor is over expressed in about 25% of all breast cancers, the presence of which can be confirmed by laboratory tests performed on the biopsy specimen and which is required for the drug to be effective.

Herceptin® has been shown to prolong survival in patients with HER2 positive advanced breast cancer (Stage 4) and reduce the risk of relapse in patients with early stage HER2 positive breast cancer, when used in combination with chemotherapy.

An increasing number of targeted therapies are becoming available for the treatment of breast cancer, including:

  • Pertuzumab (Perjeta® targets HER2)
  • Lapatinib (Tykerb®targets HER2 and EGFR)
  • Palbociclib (Ibrance® targets cell cycle pathway in hormone positive breast cancers)
  • Ribociclib (Kisqali® targets cell cycle pathway in hormone positive breast cancers in hormone positive breast cancers)
  • Everolimus (Afinitor® targets mTOR pathway in hormone positive breast cancers)

Patients who receive targeted therapies may still experience side effects but these are generally milder and less common compared to chemotherapy.

Breast Cancer - Preparing for surgery

Breast Cancer - Post-surgery care

The information provided is not intended as medical advice. Terms of use. Information provided by SingHealth

TOP
Discover articles,videos, and guides afrom Singhealth's resources across the web. These information are collated, making healthy living much easier for everyone.